Literature DB >> 8757874

Role of nitric oxide in host defense against an extracellular, metazoan parasite, Brugia malayi.

T V Rajan1, P Porte, J A Yates, L Keefer, L D Shultz.   

Abstract

The mechanisms by which mammalian hosts eliminate microparasites such as bacteria and viruses are well established. In viral infections, these mechanisms include the interferons, neutralizing and opsonizing antibodies, and cytotoxic T lymphocytes. In bacterial infections, polymorphonuclear leukocytes and macrophages, often facilitated by opsonizing antibodies, ingest the infectious agent and mediate host defense. In addition, complement, in the presence of specific antibodies directed against surface antigens, can lyse certain bacterial pathogens. In contrast, our understanding of the host defenses against metazoan, extracellular parasites is less well grounded. We obtained data by two different approaches to document the role of nitric oxide (NO) as a mediator of host defense against a human nematode parasite. First, treatment of immunocompetent, nonpermissive mice with an inhibitor of NO synthase abrogated resistance to Brugia malayi, one of the causative agents of human lymphatic filariasis. Second, treatment of permissive, immunodeficient mice with a compound that releases NO conferred resistance to infection. These data reinforce studies by James and her coworkers (I. P. Oswald, T. A. Wynn, A. Sher, and S. L. James, Comp. Biochem. Physiol. Pharmacol. Toxicol. Endocrinol. 108:11-18, 1994) on the role of NO in defense against trematode parasites and of Kanazawa et al. (T. Kanazawa, H. Asahi, H. Hata; K. Machida, N. Kagei, and M. J. Stadecker, Parasite Immunol. 15: 619-623, 1993) on cestode parasites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757874      PMCID: PMC174228          DOI: 10.1128/iai.64.8.3351-3353.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

Review 1.  NO as an effector molecule of parasite killing: modulation of its synthesis by cytokines.

Authors:  I P Oswald; T A Wynn; A Sher; S L James
Journal:  Comp Biochem Physiol Pharmacol Toxicol Endocrinol       Date:  1994-05

Review 2.  Regulation of biosynthesis of nitric oxide.

Authors:  C Nathan; Q W Xie
Journal:  J Biol Chem       Date:  1994-05-13       Impact factor: 5.157

3.  Susceptibility of Brugia malayi and Onchocerca lienalis microfilariae to nitric oxide and hydrogen peroxide in cell-free culture and from IFN gamma-activated macrophages.

Authors:  M J Taylor; H F Cross; A A Mohammed; A J Trees; A E Bianco
Journal:  Parasitology       Date:  1996-03       Impact factor: 3.234

4.  Infectivity and normal development of third stage Brugia malayi maintained in vitro.

Authors:  J A Yates; K A Schmitz; F K Nelson; T V Rajan
Journal:  J Parasitol       Date:  1994-12       Impact factor: 1.276

Review 5.  Antiparasitic effects of nitric oxide in an in vitro murine model of Chlamydia trachomatis infection and an in vivo murine model of Leishmania major infection.

Authors:  M L Woods; J Mayer; T G Evans; J B Hibbs
Journal:  Immunol Ser       Date:  1994

6.  Development of Brugia pahangi in normal and nude mice.

Authors:  A L Vincent; W A Sodeman; A Winters
Journal:  J Parasitol       Date:  1980-06       Impact factor: 1.276

7.  Role of polyamines in gastroprotection induced by epidermal growth factor.

Authors:  T Brzozowski; D Drozdowicz; J Majka; J Polonczyk-Pytko; S J Konturek
Journal:  J Physiol Pharmacol       Date:  1991-06       Impact factor: 3.011

8.  Protective immunity to Brugia malayi larvae in BALB/c mice: potential of this model for the identification of protective antigens.

Authors:  C K Carlow; M Philipp
Journal:  Am J Trop Med Hyg       Date:  1987-11       Impact factor: 2.345

9.  Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.

Authors:  J A Corbett; R G Tilton; K Chang; K S Hasan; Y Ido; J L Wang; M A Sweetland; J R Lancaster; J R Williamson; M L McDaniel
Journal:  Diabetes       Date:  1992-04       Impact factor: 9.461

10.  The immunodeficient scid mouse as a model for human lymphatic filariasis.

Authors:  F K Nelson; D L Greiner; L D Shultz; T V Rajan
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  24 in total

1.  Effect of Certain Antibiotics Against Filarial Parasite Brugia malayi In Vitro: Possible Role of Oxidative Stress.

Authors:  Rachna Sabharwal Mahajan; Anandharaman Veerpathran; Gajalakshmi Dakshinamoorthy; Richa Dwarkaprasad Sharma; Kalyan Goswami; Maryada Venkatarami Reddy
Journal:  Indian J Clin Biochem       Date:  2010-08-25

2.  S-Nitrosated Polypropylene Sulfide Nanoparticles for Thiol-Dependent Transnitrosation and Toxicity Against Adult Female Filarial Worms.

Authors:  Alex Schudel; Timothy Kassis; J Brandon Dixon; Susan N Thomas
Journal:  Adv Healthc Mater       Date:  2015-05-04       Impact factor: 9.933

3.  Molecular evidence for apoptosis in microfilariae of Wuchereria bancrofti induced by diethylcarbamazine.

Authors:  C A Peixoto; A C O Santos; C F J Ayres
Journal:  Parasitol Res       Date:  2008-05-23       Impact factor: 2.289

4.  Down regulation of macrophage activation in Brugia pahangi-infected jirds (Meriones unguiculatus).

Authors:  C Nasarre; J L Krahenbuhl; T R Klei
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

5.  Cytostatic and cytotoxic effects of activated macrophages and nitric oxide donors on Brugia malayi.

Authors:  G R Thomas; M McCrossan; M E Selkirk
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 6.  Immunopathogenesis of lymphatic filarial disease.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Semin Immunopathol       Date:  2012-10-03       Impact factor: 9.623

7.  Chitosan and chitosan nanoparticles as adjuvant in local Rift Valley Fever inactivated vaccine.

Authors:  Ashgan F El-Sissi; Farida H Mohamed; Nadia M Danial; Ali Q Gaballah; Korany A Ali
Journal:  3 Biotech       Date:  2020-02-04       Impact factor: 2.406

8.  The effects of diethylcarbamazine on the ultrastructure of microfilariae of Wuchereria bancrofti in vivo and in vitro.

Authors:  C A Peixoto; A Rocha; A Aguiar-Santos; M S Florêncio
Journal:  Parasitol Res       Date:  2004-03-09       Impact factor: 2.289

9.  Alternatively activated and immunoregulatory monocytes in human filarial infections.

Authors:  Subash Babu; V Kumaraswami; Thomas B Nutman
Journal:  J Infect Dis       Date:  2009-06-15       Impact factor: 5.226

Review 10.  Nitric oxide and respiratory helminthic diseases.

Authors:  Antonio Muro; José-Luís Pérez-Arellano
Journal:  J Biomed Biotechnol       Date:  2010-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.